1041 | Well ye | Mary Johnson | 10/18/2012 10:55:00 AM |
1040 | I think | theellasmith | 10/18/2012 10:53:24 AM |
1039 | Green reminder | Mary Johnson | 10/18/2012 10:51:42 AM |
1038 | You are | Mary Johnson | 10/18/2012 10:45:36 AM |
1037 | Do you | theellasmith | 10/18/2012 10:45:00 AM |
1036 | I agree | aleksdavis | 10/18/2012 10:42:22 AM |
1035 | The | Mary Johnson | 10/18/2012 10:41:32 AM |
1034 | AGIJ - load up! | theellasmith | 10/18/2012 10:38:45 AM |
1033 | Imo we | Mary Johnson | 10/18/2012 10:37:34 AM |
1032 | Exactly | aleksdavis | 10/18/2012 10:37:26 AM |
1031 | AGIJ - resistance is close | theellasmith | 10/18/2012 10:34:42 AM |
1030 | Third t | aleksdavis | 10/18/2012 10:31:12 AM |
1029 | AGIJ - be informed | theellasmith | 10/18/2012 10:28:28 AM |
1028 | Mens skin care growthNPD Study Shows Potential | mwirmm | 10/18/2012 7:53:59 AM |
1027 | Thanks | mwirmm | 10/18/2012 7:50:56 AM |
1026 | Thats t | mwirmm | 10/18/2012 7:43:05 AM |
1025 | Well hi | mwirmm | 10/18/2012 7:40:17 AM |
1024 | Crossing my fingers for that | Milly Joel | 10/18/2012 7:37:18 AM |
1023 | Good sh | mwirmm | 10/18/2012 6:54:18 AM |
1022 | Well it | mwirmm | 10/18/2012 6:53:05 AM |
1021 | AGIJ Chart | John Howard | 10/18/2012 6:49:41 AM |
1020 | Nice catch, I've been analyzing AGIJ's chart | John Howard | 10/18/2012 6:38:55 AM |
1019 | People | John Howard | 10/18/2012 6:35:07 AM |
1018 | that'r | John Howard | 10/18/2012 6:32:08 AM |
1017 | Maybe new investors are unaware of the AGIJ's | Milly Joel | 10/18/2012 6:30:15 AM |
1016 | I think | John Howard | 10/18/2012 6:29:42 AM |
1015 | Definit | John Howard | 10/18/2012 6:27:07 AM |
1014 | Yearly overview Last year in the very same | Milly Joel | 10/18/2012 6:24:55 AM |
1013 | Patience pay off For a month AGIJ's PPS is | Milly Joel | 10/18/2012 6:17:32 AM |
1012 | Ready for the breakthrough Current price is | Milly Joel | 10/18/2012 6:12:34 AM |
1011 | Experts Opinion Short term indicator is green, we | Milly Joel | 10/18/2012 6:10:46 AM |
1010 | I am de | Mary Johnson | 10/17/2012 1:57:43 PM |
1009 | Well I | Mary Johnson | 10/17/2012 1:54:20 PM |
1008 | What do | theellasmith | 10/17/2012 1:52:27 PM |
1007 | You are | Mary Johnson | 10/17/2012 1:51:49 PM |
1006 | Conside | theellasmith | 10/17/2012 1:50:06 PM |
1005 | The ent | theellasmith | 10/17/2012 1:46:56 PM |
1004 | AGIJ - incoming? | theellasmith | 10/17/2012 1:45:08 PM |
1003 | I think | Mary Johnson | 10/17/2012 1:45:02 PM |
1002 | AGIJ - don't miss it | theellasmith | 10/17/2012 1:41:32 PM |
1001 | Short run | Mary Johnson | 10/17/2012 1:33:32 PM |
1000 | They wi | aleksdavis | 10/17/2012 11:19:58 AM |
999 | Can you | aleksdavis | 10/17/2012 11:15:13 AM |
998 | I think | aleksdavis | 10/17/2012 11:07:59 AM |
997 | Looks g | aleksdavis | 10/17/2012 11:02:14 AM |
996 | 7 Day A | aleksdavis | 10/17/2012 10:51:56 AM |
995 | I think | mwirmm | 10/17/2012 10:10:15 AM |
994 | Somethi | mwirmm | 10/17/2012 10:10:01 AM |
993 | Opinion | mwirmm | 10/17/2012 10:09:36 AM |
992 | Going s | mwirmm | 10/17/2012 10:08:59 AM |
Recent Articles
- Social Media Influencers Drive Change Among Young Adults
- Ascential Technologies Enhances Customer Service with Care
- Royal Canin Celebrates National Pet Wellness Day with New Offerings
- Attorney Dick Harpootlian Unveils True Crime Book 'Dig Me A Grave'
- Sell With Isaac Celebrates Stellar 5-Star Reviews from Clients
- Exciting Developments at Trident Resources: Gold Drilling Plans Ahead
- Fly-E Group, Inc. Engages with Investors at Major NYC Conference
- Innovative Mobile Leukapheresis Center Revolutionizes Therapies
- Daxor's Blood Volume Analysis Expands to New Medical Facilities
- Novo Nordisk Unveils New Insights on Semaglutide at ECO 2025
- Boehringer Ingelheim Advances Innovative GA Treatment Trials
- How College Graduates Can Align Education with Career Success
- Canadians Embrace Homegrown Road Trips, Avoid U.S. Travel
- Significant Inventory Growth Indicated by Deposco Data Insights
- Consumer Concerns Rise Amidst Tariff-Induced Price Pressures
- Nokia Corporation's Recent Share Transfers and Future Innovations
- Lassila & Tikanoja's Recent Share Transfer Announcement
- Liberty Defense Excels in Security Testing for AVIATION Industry
- Service Trade Pros Unveils New Emergency Electrical Services
- PeerGame Elevates Gaming Experience with WalletConnect Partnership
- Vaxil Bio Ltd. Announces Share Consolidation Steps
- ParaZero Gains Major European Demand with SafeAir™ M4 Order
- Peabody's Board Approves Dividend for Shareholders in 2025
- GXO Logistics' Strategic Move into Healthcare Innovations
- Heron Therapeutics Reports Strong First Quarter Financials
- Bioventus Inc. Reports Q1 Financial Results and Guidance
- Peabody's Q1 Performance Highlights: Key Financial Metrics
- Zevra Therapeutics Announces Q1 2025 Financial Results Schedule
- Genie Energy Reports Strong Q1 2025 Financial Performance
- Explore The Future of Smart Home Technology at Canton Fair
- Caliber Partners with Hyatt for New Hotel Developments Across U.S.
- Stardust Power to Report Q1 2025 Financial Results Soon
- Sensei Biotherapeutics Insights on Q1 2025 Results and Progress
- Kura Oncology's Exciting Participation at Healthcare Conference 2025
- CorMedix Inc. Showcases Strong Financial Growth in Q1 2025
- Anavex Life Sciences Prepares to Share Q2 Financial Insights
- OnKure Therapeutics Unveils Financial Progress and Key Updates
- Altimmune's Upcoming Financial Results Announcement for 2025
- Highlights from Amerigo Resources Ltd.'s Annual Meeting Results
- FTI Consulting Welcomes Veteran Leader to Energy Division
- Pony AI and Uber Form Alliance to Revolutionize Mobility
- Jeffs’ Brands Announces Significant Strategic Transactions
- Caledonia Mining Corporation’s AGM Outcome: Key Insights
- Niall Prendiville Takes CPO Role at CSafe to Boost Innovation
- Key Insights on Alpha Group International's Investor Disclosure
- Ballard Power Systems Shows Growth in Recent Financial Metrics
- Sunstone Hotel Investors Shines in Latest Financial Report
- Leadership Transition at TransDigm: New CEO Announcement
- Impressive Growth: MSG Entertainment's Active Third Quarter Reveal
- Heron Therapeutics and Mylan Reach Settlement on Key Patents